NAII

Business Context and Reporting Period

Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1997 (Third Quarter of Fiscal 1997)
Business Overview: The Company operates in the multi-level distribution and weight loss industry segments, manufacturing and distributing health and wellness products. It includes wholly-owned subsidiaries such as Millennium Health International, Inc. and CellLife International, Inc.

Key Financial Metrics

Material Changes vs. Prior Period

• Quarterly Revenue Decline: Net sales for the quarter decreased by 11% ($1.4 million) compared to the prior year quarter. This was primarily driven by a major client building inventory in the prior quarter followed by reduced demand in the current quarter.
• International Sales Drop: International sales fell to $0.5 million for the quarter (from $0.8 million) and $1.3 million for the nine-month period (from $2.6 million), attributed to a major client restructuring European operations.
• Margin Compression: Quarterly gross margins decreased to 25.1% from 27.0% due to a product mix skewed toward price-sensitive bulk sales. However, nine-month margins improved slightly to 26.3% from 25.9%.
• Expense Growth: Selling, general, and administrative (SG&A) expenses increased as a percentage of revenue to 17.0% for the quarter (from 13.8%) due to costs associated with new clinical studies and the establishment of a new tablet manufacturing facility.
• Inventory Build-up: Inventory increased by $2.6 million to $8.96 million, driven by forward purchases of raw materials.

Outlook, Risks, and Management Commentary

• Liquidity Position: The Company maintains strong liquidity with working capital of approximately $12.5 million. It holds a revolving line of credit of up to $3.0 million (secured by receivables, inventory, and equipment) with $350,000 drawn as of March 31, 1997.
• Capital Expenditures: Management anticipates spending approximately $300,000 on production equipment and $400,000 on leasehold improvements in the fourth quarter, funded by operating cash flow and credit lines.
• Customer Concentration Risk: The Company relies heavily on a few major customers. In the nine months ended March 31, 1997, five customers accounted for 64% of total sales. The loss of any single major customer could have an adverse short-term impact.
• New Pension Plan: Effective January 1, 1997, the Company adopted a defined benefit pension plan. Estimated costs for the quarter included $44,000 in current service cost and $23,000 in amortized prior service cost.
• Legal Proceedings: The Company is involved in various ordinary course legal actions, which management does not expect to have a material adverse impact.

Investor Verification Checklist

• Customer Dependency: Verify the stability of the top five customers, particularly the major client in the multi-level distribution segment responsible for 36% of nine-month sales.
• Inventory Valuation: Assess the risk of obsolescence or write-downs given the $2.6 million increase in inventory levels relative to sales trends.
• International Exposure: Monitor the restructuring of the major European client and its potential long-term impact on the $1.3 million international revenue stream.
• Debt Covenants: Review the terms of the $3.0 million revolving credit line expiring December 5, 1997, to ensure renewal certainty.
• Capital Project ROI: Track the performance of the new tablet manufacturing facility and clinical studies to ensure they generate expected future revenue to offset current SG&A increases.